Micrornas in prostate cancer: an overview

Oncotarget. 2017 Jul 25;8(30):50240-50251. doi: 10.18632/oncotarget.16933.

Abstract

Prostate cancer is the second highest cause of cancer mortality after lung tumours. In USA it affects about 2.8 million men and the incidence increases with age in many countries. Therefore, early diagnosis is a very important step for patient clinical evaluation and for a selective and efficient therapy. The study of miRNAs' functions and molecular mechanisms has brought new knowledge in biological processes of cancer. In prostate cancer there is a deregulation of several miRNAs that may function as tumour suppressors or oncogenes. The aim of this review is to analyze the progress made to our understanding of the role of miRNA dysregulation in prostate cancer tumourigenesis.

Keywords: biomarkers; microRNAs; oncogenic miRNAs; prostate cancer; tumor suppressor miRNAs.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Genes, Tumor Suppressor / physiology*
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • MicroRNAs